554
Participants
Start Date
October 31, 2005
Primary Completion Date
September 30, 2008
Study Completion Date
September 30, 2008
eptacog alfa (activated)
"Sterile, freeze-dried powder in single-use vials to be reconstituted with sterile water for injection.~Three doses of 200, 100 and 100 mcg/kg to be administered bolus i.v. (intravenous) over approx. three hours."
placebo
placebo
Budapest
Sandton
Prague
Vouliagment
Madrid
Mainz
Paris La Défense Cedex
Novo Nordisk Clinical Trial Call Center, Princeton
Säo Paulo
Kowloon
Alphen aan den Rijn
Rome
Zurich
Crawley
Lead Sponsor
Novo Nordisk A/S
INDUSTRY